Physician profile
Benjamin Gary Seeman
NPI 1750426987
$21,168.87
in general payments reported to CMS, 2019-2025
64 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,834 · 2021: $953 · 2022: $1,165 · 2023: $989 · 2024: $3,038 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,225 · Travel and Lodging: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,224.82 |
| Travel and Lodging | $1,919.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $9,846.54 | 2019-2020 | |
| Stryker Corporation | $1,427.22 | 2020-2025 | Avaflex, Vertaplex, Spinejack |
| Si-Bone, INC. | $1,344.30 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $1,339.18 | 2024 | Iovera, Zilretta |
| Medtronic, INC. | $1,253.43 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Horizon Therapeutics Plc | $798.11 | 2019-2022 | |
| Stimwave Technologies Incorporated | $449.94 | 2019 | |
| Ibsa Pharma INC. | $386.46 | 2021-2025 | Tirosint, Licart, Tirosint |
| Nalu Medical, INC. | $366.74 | 2020 | |
| Scilex Pharmaceuticals INC. | $302.06 | 2019-2022 | |
| Mml US, INC. | $285.90 | 2025 | Reactiv8 |
| Tactile Systems Technology INC | $268.70 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Biohaven Pharmaceuticals, INC. | $248.56 | 2020-2021 | |
| Fidia Pharma USA INC. | $230.19 | 2019-2025 | Hymovis |
| Biohaven Pharmaceutical Holding Company LTD. | $225.80 | 2022 |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Seeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.